Literature DB >> 21152836

Lithium nephrotoxicity.

Jobson Lopes de Oliveira1, Geraldo Bezerra da Silva Júnior, Krasnalhia Lívia Soares de Abreu, Natália de Albuquerque Rocha, Luiz Fernando Leonavicius G Franco, Sônia Maria Holanda Almeida Araújo, Elizabeth de Francesco Daher.   

Abstract

Lithium has been widely used in the treatment of bipolar disorder. Its renal toxicity includes impaired urinary concentrating ability and natriuresis, renal tubular acidosis, tubulointerstitial nephritis progressing to chronic kidney disease and hypercalcemia. The most common adverse effect is nephrogenic diabetes insipidus, which affects 20-40% of patients within weeks of lithium initiation. Chronic nephropathy correlates with duration of lithium therapy. Early detection of renal dysfunction should be achieved by rigorous monitoring of patients and close collaboration between psychiatrists and nephrologists. Recent experimental and clinical studies begin to clarify the mechanisms by which lithium induces changes in renal function. The aim of this study was to review the pathogenesis, clinical presentation, histopathological aspects and treatment of lithium-induced nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21152836     DOI: 10.1590/s0104-42302010000500025

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  8 in total

Review 1.  N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.

Authors:  Hesamoddin Hosseinjani; Azadeh Moghaddas; Hossein Khalili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-19       Impact factor: 2.953

2.  Acute renal failure induced by markedly decreased appetite secondary to a depressive episode after discontinuation of long-term lithium therapy in an elderly patient with bipolar disorder.

Authors:  Akira Okada
Journal:  BMJ Case Rep       Date:  2014-05-16

3.  Spectrophotometric analysis of lithium carbonate used for bipolar disorder.

Authors:  James May; Michelle Hickey; Iasonas Triantis; Eleni Palazidou; Panayiotis A Kyriacou
Journal:  Biomed Opt Express       Date:  2015-02-27       Impact factor: 3.732

4.  Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters.

Authors:  Leonardo Tondo; Maria Abramowicz; Martin Alda; Michael Bauer; Alberto Bocchetta; Lorenza Bolzani; Cynthia V Calkin; Caterina Chillotti; Diego Hidalgo-Mazzei; Mirko Manchia; Bruno Müller-Oerlinghausen; Andrea Murru; Giulio Perugi; Marco Pinna; Giuseppe Quaranta; Daniela Reginaldi; Andreas Reif; Philipp Ritter; Janusz K Rybakowski; David Saiger; Gabriele Sani; Valerio Selle; Thomas Stamm; Gustavo H Vázquez; Julia Veeh; Eduard Vieta; Ross J Baldessarini
Journal:  Int J Bipolar Disord       Date:  2017-08-01

5.  Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Marielza Andrade Nunes; Natalia Mendes Schöwe; Karla Cristina Monteiro-Silva; Ticiana Baraldi-Tornisielo; Suzzanna Ingryd Gonçalves Souza; Janaina Balthazar; Marilia Silva Albuquerque; Ariadiny Lima Caetano; Tania Araujo Viel; Hudson Sousa Buck
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

6.  Lithium-induced Nephrotoxicity: A Case Report of Renal Cystic Disease Presenting as a Mass Lesion.

Authors:  Yvonne McCartney; Cliodhna Browne; Dilly M Little; Christian Gulmann
Journal:  Urol Case Rep       Date:  2014-09-26

Review 7.  Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review.

Authors:  Chih-Wei Hsu; Yu Lee; Chun-Yi Lee; Pao-Yen Lin
Journal:  BMC Pharmacol Toxicol       Date:  2016-12-14       Impact factor: 2.483

8.  Empagliflozin-Mediated Lithium Excretion: A Case Study and Clinical Applications.

Authors:  Guy Philip Armstrong
Journal:  Am J Case Rep       Date:  2020-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.